RxDoctor Payments Data

Christi Anderson

Family · Hotchkiss, CONPI 1346697364

Payments from drug & device makers

$3,242in general payments, 2019–2025

Across 115 payments — averaging $28.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • AbbVie$633
  • GSK$372
  • Pfizer$200
  • Astellas Pharma US Inc$164
  • Lilly USA, LLC$160
  • plus $480 from 13 others

What the payments were for

  • Travel & lodging$1,04832%
  • Food & beverage$2,19468%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,242 in reported general payments places this provider in the 90th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban37$61,224
EliquisApixaban31$45,093
MounjaroTirzepatide23$32,730
Repatha SureclickEvolocumab35$27,847
OzempicSemaglutide24$27,786
JardianceEmpagliflozin16$19,859
Nurtec OdtRimegepant Sulfate13$13,989
JanumetSitagliptin Phos/Metformin Hcl14$11,184
Bydureon BciseExenatide Microspheres13$8,991
SymbicortBudesonide/Formoterol Fumarate12$4,983
Tresiba Flextouch U-100Insulin Degludec12$4,555
Estradiol30$3,708
Albuterol Sulfate HfaAlbuterol Sulfate74$2,483
Levothyroxine Sodium290$2,279
Rosuvastatin Calcium162$1,936

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$200$59,08244 claims
Lilly USA, LLCMounjaro$160$32,73023 claims
Novo NordiskOzempic$40$27,78624 claims
Boehringer IngelheimJardiance$13$19,85916 claims
AstraZenecaSymbicort$119$4,98312 claims
AbbVieArmour Thyroid, Synthroid$633$2,92152 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,182 family providers in Colorado.

Other family in Hotchkiss

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →